“Bioprinting human organs” to be the future demand in 3D Printing Market
The global 3D bioprinting market is expected to reach USD 1,332.6 million in 2021 from USD 411.4 million, at a CAGR of 26.5% from 2016 to 2021.
The 3D bioprinting market is primarily driven by the rising demand for organ transplantation, alongside the growth in R&D activity and public & private investments for research and the rising use of 3D bioprinting in drug discovery.
Download FREE Brochure...
Cannabis Testing Services to Offer Significant Growth Opportunities
The global cannabis testing market is expected to reach USD 1,416.3 Million by 2021 from USD 822.0 Million in 2016, at a CAGR of 11.5% during the forecast period .
Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=46932450
The growth in this market is mainly driven by factors such as legalization of medical cannabis, coupled with the growing number of cannabis testing laboratories...
Protein Labeling Market 2018 By Key Players – Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), PerkinElmer Inc. (U.S.)
The Market Research on Protein Labeling, By Considering useful aspects like; Application, End Users- Global Future Forecast till 2020, published by MarketsandMarkets™, the report studies the global Protein Labeling market over the forecast period to 2020. The market is projected to reach USD 1,894.5 Million by 2020 at a CAGR of 11.7%.
Protein labeling facilitates the detection, purification, and...
Global Opportunities and Trends of Microcarrier Market
The global microcarriers market is expected to reach USD 1.61 billion by 2023 from USD 1.20 billion in 2018, at a CAGR of 6.0%. Growth in this market is driven by the rising demand for cell-based vaccines, technological advancements, and the availability of public and private funding for cell-based research.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=139831731
Based...
Technological Advancements in Disease Diagnostics Driving Microbiology Testing/Clinical Microbiology Market
The clinical microbiology market is projected to register a CAGR of 6.4%, growing from USD 3.63 billion in 2018 to USD 4.95 billion in 2023. Growth in clinical microbiology market can be attributed to factors such as rising incidence of infectious diseases and growing outbreak of epidemics and increased funding and public-private investments.
Download Free Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=219135367
The...
Transfer Membrane Market | Projected to Reach USD 187.9 Million |At a CAGR of 1.5% |Global Forecast to 2023
The global transfer membrane market is projected to reach 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5%. Factors such as increasing public and private funding for life science research, high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of this market. However,...
Nuclear Medicine/Radiopharmaceuticals Market is is projected to expand at a healthy CAGR of 5.9% by 2023
The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from an estimated USD 3.95 billion in 2018, at a CAGR of 5.9%. Growth in this market is mainly driven by factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. Moreover, the use of radiopharmaceuticals in novel neurological applications...
Increasing Incidence of Blood Disorders and Integration of Hematology Analyzers With Flow Cytometry Driving Hematology Analyzers and Reagents Market
The global hematology products market is projected to reach USD 4.98 billion by 2023 from USD 3.31 billion in 2018, at a CAGR of 8.5%. The growth in blood donation and the increasing incidence of blood disorders are the major factors driving the growth of the global hematology analyzers and reagents market.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=153222146
In this...
High Prevalence of Infectious Diseases and Various Types of Cancers– A Key Factor Driving The Market for Molecular Diagnostics
The global molecular diagnostics market is projected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at CAGR of 8.4%. Growth in this market is driven by the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular...